OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
47
Results
Show all
Save search
Copy query
Show results for
Unknown
(47)
Publication Date
Release Date
2020
(7)
2025
(6)
2024
(5)
2023
(5)
2013
(5)
2021
(4)
2022
(3)
2016
(3)
2011
(3)
2012
(2)
2019
(1)
2018
(1)
2017
(1)
2008
(1)
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
Everolimus for previously treated advanced gastric cancer: results of the randomized, double-blind, phase III GRANITE-1 study.
Not available
S-EPMC5950503
|
biostudies-literature
Cite
Comparing Low- or Standard-Dose Alteplase in Endovascular Thrombectomy: Insights From a Nationwide Registry.
Not available
S-EPMC10896194
|
biostudies-literature
Cite
Pembrolizumab or pembrolizumab plus chemotherapy versus standard of care chemotherapy in patients with advanced gastric or gastroesophageal junction adenocarcinoma: Asian subgroup analysis of KEYNOTE-062.
Not available
S-EPMC9991501
|
biostudies-literature
Cite
Xanthohumol isolated from Humulus lupulus prevents thrombosis without increased bleeding risk by inhibiting platelet activation and mtDNA release.
Not available
S-EPMC5508526
|
biostudies-literature
Cite
Metformin Uniquely Prevents Thrombosis by Inhibiting Platelet Activation and mtDNA Release.
Not available
S-EPMC5090250
|
biostudies-literature
Cite
A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data.
Not available
S-EPMC7165140
|
biostudies-literature
Cite
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer.
Not available
S-EPMC6942596
|
biostudies-literature
Cite
Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study.
Not available
S-EPMC8732926
|
biostudies-literature
Cite
ctDNA-based molecular residual disease and survival in resectable colorectal cancer.
Not available
S-EPMC11564113
|
biostudies-literature
Cite
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with metastatic colorectal cancer.
Not available
S-EPMC10220270
|
biostudies-literature
Cite
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets